SCHEMBL3787345

SCHEMBL3787345

Nc1cccc(B2OB(c3cccc(N)c3)OB(c3cccc(N)c3)O2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.50
CASP1 P29466 1/20 0.50
RECQL P46063 1/20 0.50
ALDH1A1 P00352 5/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
CA14 Q9ULX7 2/20 0.41
CA7 P43166 1/20 0.41
MAOA P21397 4/20 0.39
LMNA P02545 2/20 0.37
KDM4E B2RXH2 2/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
ENPP2 Q13822 1/20 0.37
MEN1 O00255 2/20 0.36
PSIP1 O75475 1/20 0.36
AXL P30530 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20312402 0.82 CYP3A4 (0.46) CYP3A4CASP1RECQLALDH1A1CA12
SCHEMBL3192035 0.80 CYP3A4 (0.44) CYP3A4CASP1RECQLALDH1A1CA12
SCHEMBL18625273 0.80 CYP3A4 (0.44) CYP3A4CASP1RECQLALDH1A1CA12
SCHEMBL3197481 0.79 CYP3A4 (0.42) CYP3A4CASP1RECQLALDH1A1CA12
SCHEMBL7738382 0.77 CYP3A4 (0.41) CYP3A4CASP1RECQLALDH1A1CA12
SCHEMBL30473444 0.77 LIPG (0.51) CYP3A4CASP1RECQLCA12CA1
SCHEMBL20312431 0.77 CYP3A4 (0.41) CYP3A4CASP1RECQLALDH1A1CA12
SCHEMBL103840 0.77 LIPG (0.51) CYP3A4CASP1RECQLCA12CA1
SCHEMBL7860889 0.73 ALDH1A1 (0.42) ALDH1A1TDP1MAOATSHRMAPK1
SCHEMBL1712145 0.73 CYP3A4 (0.37) CYP3A4CASP1RECQLALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023014508-A1 REVERSIBLE EPOXY POLYMER WITH DYNAMIC BORONIC BOND ExxonMobil Technology and Engineering Company (US) 2023-02-09 WO disclosed
US-8945820-B2 Silicon-containing resist underlayer film-forming composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-02-03 US disclosed
US-8945820-B2 Silicon-containing resist underlayer film-forming composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-02-03 US disclosed
US-20130137271-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-30 US disclosed
US-20130137271-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-30 US disclosed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 CYP3A4 177/4885CASP1 3772/4885RECQL 1576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.